
The findings underscore the need for vaccination in the battle against COVID-19.
The findings underscore the need for vaccination in the battle against COVID-19.
The maker of an antibody cocktail announced that it was able to prevent 100% of symptomatic infections and reduced overall infections (both symptomatic and asymptomatic) by half.
At-risk people diagnosed with COVID-19 across the United States and Canada can participate in the testing of a common antidepressant.
“I want you to see me in real time as I undergo this process and as my body adapts to having this medicine injected into my arm,” Dr. Ebony Jade Hilton said. “I’m hoping that in that transparency, you will be able to make a better decision for you and yours about receiving the vaccine.”
Here's an article I think you'll enjoy on four COVID-19 therapies that are being tested in clinical trials here at UVA Health.
The first COVID-19 vaccine could arrive soon -- possibly in the next few weeks. Here a link to some info about what to expect.